AIRLINK 79.41 Increased By ▲ 1.02 (1.3%)
BOP 5.33 Decreased By ▼ -0.01 (-0.19%)
CNERGY 4.38 Increased By ▲ 0.05 (1.15%)
DFML 33.19 Increased By ▲ 2.32 (7.52%)
DGKC 76.87 Decreased By ▼ -1.64 (-2.09%)
FCCL 20.53 Decreased By ▼ -0.05 (-0.24%)
FFBL 31.40 Decreased By ▼ -0.90 (-2.79%)
FFL 9.85 Decreased By ▼ -0.37 (-3.62%)
GGL 10.25 Decreased By ▼ -0.04 (-0.39%)
HBL 117.93 Decreased By ▼ -0.57 (-0.48%)
HUBC 134.10 Decreased By ▼ -1.00 (-0.74%)
HUMNL 7.00 Increased By ▲ 0.13 (1.89%)
KEL 4.67 Increased By ▲ 0.50 (11.99%)
KOSM 4.74 Increased By ▲ 0.01 (0.21%)
MLCF 37.44 Decreased By ▼ -1.23 (-3.18%)
OGDC 136.70 Increased By ▲ 1.85 (1.37%)
PAEL 23.15 Decreased By ▼ -0.25 (-1.07%)
PIAA 26.55 Decreased By ▼ -0.09 (-0.34%)
PIBTL 7.00 Decreased By ▼ -0.02 (-0.28%)
PPL 113.75 Increased By ▲ 0.30 (0.26%)
PRL 27.52 Decreased By ▼ -0.21 (-0.76%)
PTC 14.75 Increased By ▲ 0.15 (1.03%)
SEARL 57.20 Increased By ▲ 0.70 (1.24%)
SNGP 67.50 Increased By ▲ 1.20 (1.81%)
SSGC 11.09 Increased By ▲ 0.15 (1.37%)
TELE 9.23 Increased By ▲ 0.08 (0.87%)
TPLP 11.56 Decreased By ▼ -0.11 (-0.94%)
TRG 72.10 Increased By ▲ 0.67 (0.94%)
UNITY 24.82 Increased By ▲ 0.31 (1.26%)
WTL 1.40 Increased By ▲ 0.07 (5.26%)
BR100 7,526 Increased By 32.9 (0.44%)
BR30 24,650 Increased By 91.4 (0.37%)
KSE100 71,971 Decreased By -80.5 (-0.11%)
KSE30 23,749 Decreased By -58.8 (-0.25%)
World

Norway approves AstraZeneca vaccine for over 65s

  • On Monday, Norway reported 632 Covid-related deaths since the beginning of the pandemic.
Published March 9, 2021

OSLO: Norway on Tuesday recommended that AstraZeneca's Covid-19 vaccine be used for people over the age of 65 in light of new studies and amid hopes it would speed up vaccinations of the elderly.

The Nordic country had initially restricted the use of the vaccine to those under the age of 65 on the grounds that the Anglo-Swedish firm had not conducted enough research on people above that age.

Following in the footsteps of France, Germany, Italy and several Nordic neighbours, Norway's public health agency said it was now recommending the vaccine for all people over the age of 18, based on British studies now conducted on elderly people.

The government said Tuesday it would follow the agency's recommendation.

Norway also wants to increase the waiting period between the first and second doses of the Pfizer/BioNtech and Moderna vaccines from three to six weeks, a move that still requires a final approval from the public health agency.

The agency has also been tasked with studying whether the interval can be extended beyond six weeks in order to allow a greater number of people to quickly receive a first dose.

"We now expect all adults to be offered a vaccine by or during the summer," Prime Minister Erna Solberg told parliament.

She also gave local medical authorities increased powers to try to curb a recent surge of infections in Norway.

While the country has one of the lowest incidence rates in Europe, the number of cases has soared lately.

"We still have a steep hill ahead of us but if we make it, the goal of a return to a more normal life will be within reach," Solberg said.

"If we manage to keep the epidemic under control in March-April, we can begin to reopen (the country) in May," she said.

If not, authorities may need to impose new nationwide restrictions, including a ban on serving alcohol and the closure of various public establishments, she warned.

More than 391,000 people had by Sunday received at least one jab in the country of 5.4 million people, and almost 210,000 had gotten two doses.

On Monday, Norway reported 632 Covid-related deaths since the beginning of the pandemic.

Comments

Comments are closed.